JPRN-UMIN000009007已完成未知
Randomized, single-blinded, placebo-controlled, parallel-group trial to clarify the acute effect of single nebulized Amphotericin B on cough symptoms in bronchodilator resistive cough patients - Effect of single nebulized Amphotericin B on cough in bronchodilator resistive cough
Ishikawa-ken Saiseikai Kanazawa Hospital.0 个研究点目标入组 28 人开始时间: 2012年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients having abnormal shadow on chest X-ray 2)Patients having wheezing audible 3)Patients having obstructive disorders in pulmonary function testing 4)Patients having severe complications 5)Patients having pulmonary tuberclosis
研究者
相似试验
已完成
不适用
Randomized, single-blinded, placebo-controlled, parallel-group trial to clarify the efficacy of 3 times nebulized Amphotericin B on cough symptoms in chronic cough patients with Bjerkandera adusta culturedChronic cough with basidiomycetous fungi cultured from their sputum or pharyngeal swabJPRN-UMIN000010030Ishikawa-ken Saiseikai Kanazawa Hospital.10
进行中（未招募）
1 期
Randomized, single-blind, placebo controlled multicenter phase III study to assess the efficacy and safety of expanded autologous adipose-derived stem cells (eASCs) (CX-401), for treatment of complex perianal fistulas in perianal Crohn?s disease. FATT II: Fistula Advanced Therapy Trial (II) - FATT IIEUCTR2008-004286-25-NLCELLERIX S.A.156
已完成
3 期
Randomized, single-blind, placebo controlled multicenter phase III study to assess the efficacy and safety of expanded autologous adipose-derived stem cells (eASCs) (CX-401), for treatment of complex perianal fistulas in Crohn*s disease.NL-OMON35164Cellerix S.A.18
已完成
不适用
Randomized, placebo-controlled, single blind, crossover clinical study to evaluate the relationship between subjective sedation after a single dose of ebastine and gene polymorphisms in pharmacodynamics and pharmacokinetics of ebastine. The healthy Japanese volunteers had experience with subjective sedation after taking the second generation histamine H1 receptor antagonists.Japanese healthy volunteers who had experience with subjective sedation after taking the second generation of histamine H1 receptor antagonist.JPRN-UMIN000000567Showa University School of Pharmaceutical Sciences Department of Clinical Pharmacy20
进行中（未招募）
不适用
A clinical trial to investigate if different doses of BAY 85-3934 are safe and effective in patients with anaemia due to chronic kidney disease, who are not currently receiving treatment to help produce red blood cells and are not undergoing dialysis treatment.EUCTR2013-001193-14-PLBayer HealthCare AG120